首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Under existing law, a new drug may be labeled, promoted, and advertised only for those conditions in which safety and effectiven
Under existing law, a new drug may be labeled, promoted, and advertised only for those conditions in which safety and effectiven
admin
2011-02-11
28
问题
Under existing law, a new drug may be labeled, promoted, and advertised only for those conditions in which safety and effectiveness have been demonstrated and of which the Food and Drug Administration (FDA) has approved, or socalled "approved uses." Other uses have come to be called "unapproved uses" and cannot be legally promoted. In a real sense, the term "unapproved" is a misnomer because it includes in one phrase two categories of marketed drugs that are very different; drugs which are potentially harmful and will never be approved, and already approved drugs that have "unapproved" uses. It is common for new research and new insights to demonstrate valid new uses for drugs already on the market. Also, there arc numerous examples of medical progress resulting from the serendipitous observations and therapeutic innovations of physicians, both important methods of discovery in the field of therapeutics. Before such advances can result in new indications for inclusion in drug labeling, however, the available data must meet the legal standard of substantial evidence derived from adequate and well-controlled clinical trials. Such evidence may require time to develop, and, without initiative on the part of the drug firm, it may not occur at all for certain uses. However, because medical literature on new uses exists and these uses arc medically beneficial, physicians often use these drugs for such purposes prior to FDA review or changes in labeling. This is referred to as "unlabeled uses" of drugs.
A different problem arises when a particular use for a drug has been examined scientifically and has been found to be ineffective or unsafe, and yet physicians who either are uninformed or who refuse to accept the available scientific evidence continue to use the drug in this way. Such use may have been reviewed by the FDA and rejected, or, in some cases, the use may actually be warned against in the labeling. This subset of uses may be properly termed "disapproved uses."
Government policy should minimize the extent of unlabeled uses. If such uses are valid—and many are—it is important that scientifically sound evidence supporting them be generated and that the regulatory system accommodate them into drug labeling. Continuing rapid advances in medical care and the complexity of drug usage, however, makes it impossible for the government to keep drug labeling up to date for every conceivable situation. Thus, when a particular use of this type appears, it is also important, and in the interest of good medical cure, that no stigma be attached to "unapproved usage" by practitioners while the formal evidence is assembled between the time of discovery and the time the new use is included in the labeling. In the case of "disapproved uses," however, it is proper policy to warn against these in the package insert, whether use of a drug for these purposes by the uninformed or intransigent physician constitutes a violation of the current Federal Food, Drug and Cosmetic Act is a matter of debate that involves a number of technical and legal issues. Regardless of that, the inclusion of disapproved uses in the form of contraindications, warnings and other precautionary statements in package inserts is an important practical deterrent to improper use. Except for clearly disapproved uses, however, it is in the best interests of patient care that physicians not be constrained by regulatory statutes from exercising their best judgment in prescribing a chug for both its approved uses and any unlabeled uses it may have.
All of the following are mentioned in the passage as reasons for allowing unlabeled uses of drugs EXCEPT ______.
选项
A、the increased cost to the patient of buying an FDA-approved drug
B、the medical benefits which can accrue to the patient through unlabeled use
C、the time lag between initial discovery of a medical use and FDA approval of that use
D、the possibility that a medically beneficial use may never be clinically documented
答案
A
解析
细节判断题。此题可通过排除法得出结论。因为unlabeled use的好处在首尾两段都特别强调提出,因此B是错误的。C是错误的,在第一段中提到时间滞后造成药品的新用途无法及时得到肯定。第一段中提到制造商有可能未曾知道药品的其他疗效,因此D也是错误的。A是正确答案,因为课文中找不到费用足消费者要考虑的一个内容。
转载请注明原文地址:https://kaotiyun.com/show/ZpeO777K
0
专业英语八级
相关试题推荐
TheRomanticwritersintheAmericanliteraryhistoryfocusedonallthefollowingissuesEXCEPT
1WhenAmericahadanenergycrisis,ourleadersrespondedbycreatingtheDepartmentofEnergy.Whenweperceivedshortcomi
Thefoxreallyexasperatedthemboth.Assoonastheyhadletthefowlsout,intheearlysummermornings,theyhadtotakethei
根据“十五”期间的形势和任务,《纲要》提出今后五年经济和社会发展的主要目标是:国民经济保持较快发展速度,经济结构战略性调整取得明显成效,经济增长质量和效益显著提高,为到2010年国内生产总值比2000年翻一番奠定坚实基础。国有企业建立现代企业制度取得重大进
EmilyBrontewasmostfamousfor
ThenovelPrideandPrejudicewaswrittenbythefamouswomanwriter______.
Growingconcernsoverthesafetyandefficacyofanti-depressantdrugsprescribedtochildrenhavecaughttheeyeofCongressan
Inplaceoftheking,twochiefexecutiveswerechosenannuallybythewholebodyofcitizens.Thesewereknownaspraetors,or
Theconditionsofartshouldbesimple.Agreatdealmoredependsupontheheartthanuponthehead.Appreciationofartisnot
汉、唐时期既是经济繁荣的盛世,也是中外交流的盛世。张骞出使西域,开拓举世闻名的“丝绸之路”;玄奘万里取经,带回南亚国家的古老文化;明代郑和七下西洋,把中华文化传向远方的国度。但是后来,特别是清代晚期,封建统治者实行闭关锁国的政策,阻碍了中国的进步和中外交流
随机试题
鼓吹诗的“三美”,即音乐美、建筑美、绘画美的诗人是________。
关节出血常见的疾病是
A、通过牙体中心的一条假想轴B、牙体各轴面最突出的部分C、牙冠上三面相交处成一点所成的角D、牙与牙在邻面互相接触的部位E、牙冠上两面相交处成一线,所成的角在牙体应用术语中,属外形高点的定义是
财政分配的主体是国家,这包括几层含义?
()是指个人对外贸易经营者、个体工商户按照规定开立的用以办理经常项目项下经营性外汇收支的账户。
下列关于零基预算的说法错误的是( )。
企业采取保守型营运资本投资政策,产生的结果是()。
下列有关进口货物原产地的确定,不符合我国关税相关规定的是()。
甲、乙、丙、丁四人共同投资一个项目,已知甲的投资额比乙、丙二人的投资额之和高20%,丙的投资额是丁的60%,总投资额比项目的资金需求高。后来丁因故临时撤资,剩下三人的投资额之和比项目的资金需求低。则乙的投资额是项目资金需求的:
交管局要求司机在通过某特定路段时,在白天也要像晚上一样使用大灯,结果发现这条路上的年事故发生率比从前降低了15%。他们得出结论说:如果在全市范围内都推行该项规定会同样地降低事故发生率。以下哪项如果为真,最能支持上述论证的结论?
最新回复
(
0
)